(Q110492151)

1

0 references

Lu Lu

2

0 references

Zheng Peng

3

0 references

Lin-Lei Chen

4

0 references

Xinjin Meng

5

0 references

Chuyuan Zhang

6

0 references

Jonathan Daniel Ip

7

0 references

Wan-Mui Chan

8

0 references

Allen Wing-Ho Chu

9

0 references

Kwok-Hung Chan

10

0 references

Dong-Yan Jin

11

0 references

Honglin Chen

12

0 references

Kwok-Yung Yuen

13

0 references

Kelvin Kai-Wang To

Emerging Microbes & Infections

14

0 references

publication date

24 December 2021

0 references

published in

0 references

page(s)

1-18

0 references

copyright license

Creative Commons Attribution 4.0 International

start time

19 January 2022

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets

1 reference

https://api.crossref.org/works/10.1080/22221751.2021.2023329

Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses

9 January 2022

1 reference

https://api.crossref.org/works/10.1080/22221751.2021.2023329

COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing

9 January 2022

1 reference

https://api.crossref.org/works/10.1080/22221751.2021.2023329

Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2

9 January 2022

1 reference

https://api.crossref.org/works/10.1080/22221751.2021.2023329

Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system

9 January 2022

1 reference

https://api.crossref.org/works/10.1080/22221751.2021.2023329

Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia

9 January 2022

1 reference

https://api.crossref.org/works/10.1080/22221751.2021.2023329

Host and viral determinants for efficient SARS-CoV-2 infection of the human lung

9 January 2022

1 reference

https://api.crossref.org/works/10.1080/22221751.2021.2023329

TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction

9 January 2022

1 reference

https://api.crossref.org/works/10.1080/22221751.2021.2023329

Mechanisms of SARS-CoV-2 entry into cells

9 January 2022

1 reference

https://api.crossref.org/works/10.1080/22221751.2021.2023329

SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes

9 January 2022

1 reference

https://api.crossref.org/works/10.1080/22221751.2021.2023329

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

9 January 2022

1 reference

https://api.crossref.org/works/10.1080/22221751.2021.2023329

Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study

9 January 2022

1 reference

https://api.crossref.org/works/10.1080/22221751.2021.2023329

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

9 January 2022

1 reference

https://api.crossref.org/works/10.1080/22221751.2021.2023329

The impact of spike N501Y mutation on neutralizing activity and RBD binding of SARS-CoV-2 convalescent serum

9 January 2022

1 reference

https://api.crossref.org/works/10.1080/22221751.2021.2023329

Cross-linking peptide and repurposed drugs inhibit both entry pathways of SARS-CoV-2

9 January 2022

1 reference

https://api.crossref.org/works/10.1080/22221751.2021.2023329

Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies

9 January 2022

1 reference

https://api.crossref.org/works/10.1080/22221751.2021.2023329

Low dose inocula of SARS-CoV-2 Alpha variant transmits more efficiently than earlier variants in hamsters

9 January 2022

1 reference

https://api.crossref.org/works/10.1080/22221751.2021.2023329

Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation

9 January 2022

1 reference

https://api.crossref.org/works/10.1080/22221751.2021.2023329

Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic

9 January 2022

1 reference

https://api.crossref.org/works/10.1080/22221751.2021.2023329

B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination

9 January 2022

1 reference

https://api.crossref.org/works/10.1080/22221751.2021.2023329

Transmission of Omicron (B.1.1.529) - SARS-CoV-2 Variant of Concern in a designated quarantine hotel for travelers: a challenge of elimination strategy of COVID-19

9 January 2022

1 reference

https://api.crossref.org/works/10.1080/22221751.2021.2023329

Emerging SARS-CoV-2 variants expand species tropism to murines

9 January 2022

1 reference

https://api.crossref.org/works/10.1080/22221751.2021.2023329

Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant

9 January 2022

1 reference

https://api.crossref.org/works/10.1080/22221751.2021.2023329